1063-58 A randomized placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting

Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors During Elective Coronary Revascularization

“…1, Table 1) (10,11,(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40). The studies examined a variety of clinical outcomes, including 7 that used a nonclinical primary outcome (Table 2) (23,24,26,27,30,32,34). Details of GPI administration and adjuvant medications are listed in Table 3.…”